The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Nicotinell TTS 30, 21mg/24 hours Transdermal Patch



GlaxoSmithKline Consumer Healthcare (Ireland) LimitedPA0678/123/003

Main Information

Trade NameNicotinell TTS 30, 21mg/24 hours Transdermal Patch
Active SubstancesNicotine
Dosage FormTransdermal patch
Licence HolderGlaxoSmithKline Consumer Healthcare (Ireland) Limited
Licence NumberPA0678/123/003

Group Information

ATC CodeN07BA Drugs used in nicotine dependence
N07BA01 nicotine

Status

License statusAuthorised
Licence Issued02/11/1995
Legal statusProduct not subject to medical prescription
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to the general public
Conditions of LicenceIn general sale outlets can only be sold or supplied to adults aged 18 years or above
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back